Colorectal cancer (CRC) is one of the most common malignant tumors in the world. showed that GALNT6 overexpression induced 279 genes up-regulated and 215 genes down-regulated in CRC. Troglitazone novel inhibtior GALNT6 overexpression dramatically suppressed AKT and activated CD28 signaling pathway in CRC. AKT rescue experiment found that AKT was involved in GALNT6-induced CRC cell… Continue reading Colorectal cancer (CRC) is one of the most common malignant tumors